PP

Preeti Panchal

Active Director Director DIN 07198338
DIN 07198338 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Preeti Panchal

Data last updated:

Preeti Panchal is a Director at Globax Pharma Private Limited (since 2015). The company operates in Pharma. Globax Pharma Private Limited reported revenue of ₹13 Lakh (FY 2020).

DIN 07198338
Primary Designation Director
Industry Pharma
First Appointment 19 Sep 2015
Oldest Company Age 11 yrs
Largest company Globax Pharma Private Limited · ₹13 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Globax Pharma Private Limited U51909DL2015PTC285428
Director19 Sep 20152015₹13 Lakh (FY 2020)Active

Board colleagues of Preeti Panchal

NameDINCompanyDesignation
Manoj Manu08151904Globax Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globax Pharma Private Limited
Premium access

Shareholding and investment profile for Preeti Panchal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preeti Panchal

Preeti Panchal currently holds 1 directorship: Globax Pharma Private Limited (Director, since 19 Sep 2015, revenue ₹13 Lakh (FY 2020)).

Preeti Panchal was first appointed on 19 Sep 2015 as Director at Globax Pharma Private Limited.

The current boards of Preeti Panchal's companies include Manoj Manu (Globax Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available